Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

France: The findings of a new study published in JAMA Cardiology suggest that an electrophysiological study (EPS) provides ...

Sept. 24 (UPI) --Changes in heart function observed on electrocardiograms of patients hospitalized with COVID-19 or influenza can help predict a time frame for worsening health, a study published ...

Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...

A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments. Researchers at Mayo Clinic applied artificial intelligence ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...

New data from an international study of AliveCor’s smartphone app and accompanying two-wire ECG found the mobile tool to be on par with a standard 12-lead ECG among patients presenting with ST-segment ...

Cardiologists regularly get calls from people who are freaked out by the fitness tracker on their wrist. Typically, the caller is young and healthy, maybe even a half-marathoner, says Cleveland Clinic ...

Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

A new study published in the journal of Clinical Cardiology revealed that acoustic cardiography (ACG), which combines ECG ...

ECG abnormalities detected as part of a cardiac screening program mandated by the National Basketball Association (NBA) were found in 15.6% of active players and potential draftees, a new analysis ...

AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ GuardTM, an FDA Breakthrough Device Designated AI-powered technology ...